Information Center
Your Health. Your Family. Your Choice.
|
|
National Vaccine Information Center Your Health. Your Family. Your Choice. |
MedAlerts Home |
| Case Details |
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: This spontaneous report was received from social media, refers to unspecified number of young male patients. The patient''s medical history, concurrent conditions and concomitant medications were unknown. On an unknown date, the patients were vaccinated with GARDASIL (dose, frequency, route of administration, expiry date and lot # were not specified) for prophylaxis. On an unknown date, the patients experienced injury (majority injuries) and pain (unfathomable pain). On an unknown date, the patients died due to unknown reason. It was also reported on an unknown date that, dangerous bills were passed to mandate the suspect GARDASIL (lethal injection) and also allow the minors to receive without "Parental Consent" as prophylactic treatment to prevent STD''s (sexually transmitted diseases) in millions of boys in more than 52 countries around the world. The outcome of pain and injury was unknown. The causality assessment was not reported. This was one of the several reports. | |||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? Yes Write-up: This spontaneous report was received from a journalist and refers to unspecified number of female patients of unknown age (reported as young). There was no information about the patients'' concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patients were vaccinated with GARDASIL for prophylaxis (dose, route and site of administration, lot number and expiration date were not reported). On unknown dates (reported as follow vaccinations), the patients experienced life-threatening or lethal side effects. The cause o f death was not provided. The outcome of the events was unknown. The relatedness between the events and the GARDASIL was not provided. This is one of several reports received from the same reporter. Sender''s Comments: US-009507513-1905USA003023: US-009507513-1905USA003024: US-009507513-1905USA003025: US-009507513-1905USA003113. | |||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: patient died; tested post mortem blood samples and found fragments of foreign DNA in her spleen and these were positive for human papilloma virus; This spontaneous report has been received from a physician as a social media post referring to a female patient of unknown age.Information on patient''s medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with third dose Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) (dose, anatomical location, route, lot# and expiry date was not reported) for prophylaxis. On an unknown date, the patient died in her sleep six months after her third Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) injection due to unknown reason. On an unknown date, the autopsy (reported as post-martem blood test) was performed which showed fragments of foreign deoxyribose nucleic acid (DNA) in patient''s blood and spleen and those samples were positive for human papilloma virus (HPV) (Human papilloma virus test positive). Physician also reported that it was not the result of natural HPV infection, most likely the DNA was bound to aluminum, which was also found in the patient. The physician further mentioned that HPV gene was foreign DNA and its detection six months after the injection was not normal. The physician also tested five samples of the vaccine sent from somewhere else and found HPV vaccine in each. Causality assessment between the events and the suspect therapy was unknown.; Reported Cause(s) of Death: unknown cause of death. | |||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: three days after vaccination the patient died; This spontaneous report was received from a nurse practitioner via a company representative and refers to a healthy female patient of unknown age. The patient''s concurrent conditions, medical history, concomitant therapies, drug reactions and allergies were not reported. On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), (unidentified Merck hpv vaccine administered; name, dose, route of administration, lot # and expiration date were not reported) for prophylaxis. On an unknown date, reported as three days after vaccination, the patient died. The cause of death was unknown. It was unknown if an autopsy was done. The relatedness between the patient''s death and suspect vaccine was not provided. | |||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? Yes Write-up: The patient developed a fever, was hospitalized at an unspecified hospital for an unspecified length of time; The patient "eventually died" on an unspecified date several years ago. Cause of death: unknown; This spontaneous report was received from the pharmacist via a company representative, referring to a 16-year-old female patient. The patient''s current conditions, medical history, concomitant medications, drug reactions or allergies were not reported. On an unknown date (reported as "several years ago"), the patient received unidentified Merck hpv vaccine administered (name and lot for prophylaxis (dose, strength, lot# and expiration date were not reported) or HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) as prophylaxis (dose, strength, lot# and expiration date were not reported). The patient was vaccinated at the clinic of an unspecified physician, not at a pharmacy. On an unspecified date (reported as "several years ago"), the patient developed a fever, was hospitalized at an unspecified hospital for an unspecified length of time and received an unknown type of treatment. On an unknown date, the patient eventually died from an unknown cause. It was unknown if an autopsy was performed. At the time of this report, the causality assessment between the unidentified Merck hpv vaccine administered (name and lot number not provided) and the events, were not reported. The reporter considered the event of fever to be life threatening. | |||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: died after hpv vaccine; HPV 16,11,18 (first vial tested and turn out to be positive); PQC Present: Yes; This spontaneous report was received from a consumer via social media referring to a female patient of unknown age. The patient''s concurrent conditions, medical history and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) (dose, route, lot# and expiry date were not reported) for prophylaxis. On an unknown date, the patient died after administration of quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL). It was reported that the first vial was sent to the reporter by the local paediatrician. The reporter tested the vial and was turned to be positive (Human papilloma virus test positive and product quality issue). Cause of death was unknown and it was unknown whether autopsy was performed. The outcome of papilloma viral infection and product quality issue was unknown. The reporter considered the event of death and human papilloma virus test positive as related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL). Causality assessment for product quality issue was not reported. This is one of the several reports received from the same reporter.; Sender''s Comments: US-009507513-0807USA02497:Same reporter US-009507513-1609USA002149:Same reporter; Reported Cause(s) of Death: unknown cause of death | |||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: died from Hpv vaccine; HPV 16 11 18 (first vial tested and turned out to be positive); PQC present: Yes/sent me at the first vial so i tested and it turned out to be positive altogether 16 vials; This spontaneous report was received from a consumer via social media referring to a patient of unknown age and gender. The patient''s pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (dose, anatomical location, lot# and expiry date not reported) for prophylaxis. On an unknown date, the patient died from quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL). It was reported that, the first vial was sent to the reporter by the local paediatrician. The reporter tested the vial and was turned to be positive with strains HPV 16, 11, 18 (Human papilloma virus test positive and product quality issue). Cause of death was unknown and it was unknown whether autopsy was performed. The outcome of papilloma viral infection and product quality issue was unknown. The reporter considered the event of death as related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL). Causality assessment for human papilloma virus test positive and product quality issue was not reported. This is one of the several reports received from the same reporter.; Sender''s Comments: US-009507513-1909USA012460:same reporter US-009507513-0807USA02497:same reporter; Reported Cause(s) of Death: unknown cause of death | |||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: dies from Gardasil vaccine injuries; 3 years of suffering; This information was obtained from a website and refers to a female patient of unknown age. No information regarding the patient''s pertinent medical history, concomitant medications, drug reactions and allergies was provided. On an unknown date, the patient was vaccinated with a dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) injection (dose, route of administration, lot number and expiration date were not provided). On an unknown date, the patient experienced unspecified injuries. On an unknown date, the patient experienced an unspecified adverse event, which caused suffering lasting 3 years. On an unknown date, at the age of 19 years, the patient died of the unspecified injuries. It was unknown if the autopsy was performed. The outcome of the unspecified adverse event was unknown. The reporter considered the event of unspecified injuries to be related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). The relatedness between the unspecified adverse event and quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) was not provided.; Sender''s Comments: US-009507513-1910USA012728: | |||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: After three years of suffering, 19 Year old girl dies from GARDASTL vaccine injury; This spontaneous report was received from a consumer via a company representative through an online article referring to a 19 years old female patient. Information about medical history, concurrent conditions and concomitant therapies was not provided. On an unknown date the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) (dosage detail, route, strength, lot # and expiration date were not reported) or hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) for prophylaxis (it was unclear which the two products was involved). On an unknown date (reported as after three years of suffering), the patient died from vaccine injury. It was unknown if an autopsy was performed. The reporter considered the event to be related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) or hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9).; Reported Cause(s) of Death: vaccine injury | |||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: Died unexpectedly in 2008, shortly after receiving the Gardasil human papillomavirus (HPV) vaccine; This spontaneous report was received from a lawyer via social media referring to a 21 years old female patient. Information about medical history, concurrent conditions, drug reactions/allergies and concomitant therapies was not provided. On an unknown date in 2008, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (vaccine dosage detail, route of administration, lot# and expiration date were not reported) for prophylaxis. The patient died unexpectedly shortly after receiving quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). The reporter considered death unexpectedly to be related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). | |||||||||||||||||
Link To This Search Result:
https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=16&SYMPTOMS[]=Death_%2810011906%29&VAX[]=HPV4
Copyright ©
2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166